Sign In
Buy VTRS
$16.39
+0.120 (+0.738%)
At Close: Jul 13, 2026
Is Viatris a Great Dividend Stock or Just a Value Trap?
09:53am, Thursday, 14'th Mar 2024
Viatris' high dividend yield and low valuation may look attractive to bargain hunters. However, the company's earnings nosedived last year, causing investor concern.
2 Dirt Cheap Dividend Stocks to Buy and Hold
09:45am, Monday, 11'th Mar 2024
Pfizer's slumping revenue is a temporary hiccup considering its incredibly deep pipeline. Viatris has made important changes to its business that should pay off down the road.
US FDA declines to approve Viatris's injection for multiple sclerosis
07:32am, Monday, 11'th Mar 2024
The U.S. FDA has declined to approve Viatris and Mapi Pharma's once-a-month injection for treating relapsing forms of multiple sclerosis (MS), the companies said on Monday.
Viatris' (VTRS) Generic Declines in Q4, Yupleri Sales Rise
12:26pm, Monday, 04'th Mar 2024
Viatris (VTRS) stock down after posting weaker-than-expected results from its generics business. Nevertheless, the guidance for 2024 looks encouraging.
Viatris Inc. (VTRS) Q4 2023 Earnings Call Transcript
12:25pm, Wednesday, 28'th Feb 2024
Viatris Inc. (VTRS) Q4 2023 Earnings Call Transcript
Viatris' (VTRS) Q4 Earnings and Revenues Miss Estimates
10:51am, Wednesday, 28'th Feb 2024
Viatris (VTRS) reports lower-than-expected fourth-quarter financial results, as both earnings and sales miss estimates. Stock declines in pre-market.
Viatris (VTRS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
10:36am, Wednesday, 28'th Feb 2024
While the top- and bottom-line numbers for Viatris (VTRS) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compar
3 Overextended Stocks That Need to Slash Their Dividends ASAP
03:19pm, Tuesday, 27'th Feb 2024
There are lots of overextended stocks out there falling short thanks to dividend payments that are too good to be true. The internationally known pharmaceutical company Bayer (OTCMKTS: BAYRY ) is a gr
3 Bargain Stocks to Snatch Up Before They Bounce Back
04:27pm, Monday, 26'th Feb 2024
The momentum in technology stocks has buoyed the markets to new highs, leaving investors in a dilemma. Do they chase the hot AI and technology that have outperformed or stick with bargain stocks?
Viatris (VTRS) to Report Q4 Earnings: Is a Beat in Store?
12:56pm, Friday, 23'rd Feb 2024
Viatris' (VTRS) Q4 results are likely to gain from momentum in its branded and generic businesses.
Insights Into Viatris (VTRS) Q4: Wall Street Projections for Key Metrics
10:21am, Friday, 23'rd Feb 2024
Get a deeper insight into the potential performance of Viatris (VTRS) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for s
Charts turn bullish on health-care stocks as sector takes early lead in 2024
11:29am, Tuesday, 16'th Jan 2024
Chart-watchers are growing increasingly bullish on health-care stocks now that they have become the best-performing sector of the S&P 500 so far in 2024, according to Dow Jones Market Data. Analysts h
From Euphoria To Reality: Viatris' Tale Of Market Whirlwind
12:54pm, Friday, 12'th Jan 2024
Viatris is an American pharmaceutical company formed as a result of the merger of Mylan and Upjohn. Over the past two and a half months, Viatris' share price has risen by more than 38%. Viatris' divid
Viatris Inc. (VTRS) Presents at J.P. Morgan 42nd Annual Healthcare Conference (Transcript)
06:50pm, Wednesday, 10'th Jan 2024
Viatris Inc. (VTRS) Presents at J.P. Morgan 42nd Annual Healthcare Conference (Transcript)
Are defensive sectors ready to outshine growth in 2024?
07:50am, Saturday, 06'th Jan 2024
The Health Care Select Sector SPDR Fund NYSEARCA: XLV, which has both growth and defensive characteristics, was the leader in the first week of the year. Top sector performers included Moderna Inc. NA
